Unlock instant, AI-driven research and patent intelligence for your innovation.

Small-molecule inhibitors that block the binding of covid-19 spike protein to human angiotensin-converting enzyme 2 and uses thereof

A COVID-19, small molecule inhibitor technology, applied in the fields of peptide/protein components, active ingredients of hydroxyl compounds, medical preparations containing active ingredients, etc. question

Active Publication Date: 2022-07-26
DALIAN UNIV OF TECH +1
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

For the vast number of susceptible people, the current protective products such as masks and alcohol-containing disinfection products are broad-spectrum protection, and there is no protective product that is highly effective and specific to block virus infection on the market

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Small-molecule inhibitors that block the binding of covid-19 spike protein to human angiotensin-converting enzyme 2 and uses thereof
  • Small-molecule inhibitors that block the binding of covid-19 spike protein to human angiotensin-converting enzyme 2 and uses thereof
  • Small-molecule inhibitors that block the binding of covid-19 spike protein to human angiotensin-converting enzyme 2 and uses thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0039] Example 1: Primary screening of compounds

[0040] Virtual screening is conducted with the laboratory's own 145 molecular databases and 1913 marketed small molecule drugs as screening objects. The virtual screening software used in this embodiment is Discovery Studio. According to the virtual screening score, the list of potential molecules is selected according to the molecular structure characteristics. In this example, the compounds shown in Table 1 below were selected, wherein, the disulfonated derivative of luteolin, MXCS-diSO 3 Na (DUT202001, DUT202002) were synthesized by the following example 2, resveratrol analog (DUT202003), quercetin disulfonated derivative (DUT202004) were laboratory-owned, cerulein DUT202005, acarbose DUT202006 , Aliskiren (DUT202007) and the luteolin used in the examples were purchased commercially.

[0041] Table 1 Compound Information

[0042]

[0043]

Embodiment 2

[0044] Example 2: DUT202001 [2-(4,5-dihydroxyphenyl)-5,7-dihydroxy-benzo-γ-pyrone-3′,6-disulfonate sodium (also known as: luteolin) (Sodium-3',6-disulfonate)] and DUT202002[2-(4,5-dihydroxyphenyl)-5,7-dihydroxy-benzo-γ-pyrone-3',8- Synthesis of sodium disulfonate (also known as: luteolin-3', 8-sodium disulfonate)]

[0045] Measure 4mL of concentrated sulfuric acid in a 50mL chicken heart bottle, cool it to 0°C in an ice-water bath, add 1.0g luteolin powder in batches under stirring, heat up after the addition, react at 30°C for 72h, transfer the reaction solution into 50mL The saturated aqueous sodium chloride solution was stirred, and a large amount of solid was precipitated, and it was left to stand until the solid was completely precipitated, and then suction filtration under reduced pressure. The product was dissolved in 40 mL of deionized water, the pH value was adjusted to 6-7 with sodium bicarbonate, 2.0 g of sodium chloride was added for salting out, the precipitated ...

Embodiment 3

[0048] Example 3: Activity test for blocking the binding of the receptor binding domain (RBD) of the COVID-19 spike protein to human angiotensin-converting enzyme 2 (hACE2)

[0049] Experimental materials: compounds DUT202001 and DUT202002 (synthesized in Example 2), DUT202003 and DUT202004 (laboratory); compounds DUT202005, DUT202006 and DUT202007 (purchased from Shanghai Aladdin Biochemical Technology Co., Ltd.); SARS-CoV-2S, pAX2, pHB, and ACE2-pcDNA3 (China Science and Technology Co., Ltd.); 293T cells (Shanghai Heyuan Biotechnology Co., Ltd.). The pCMV-SNAP-hACE2 plasmid, SNAP-561 fluorescent dye and RBD541-Halo-640dye were from the research group of Xu Zhaochao, Dalian Institute of Chemical Physics, Chinese Academy of Sciences.

[0050] Specifically, the test steps are as follows:

[0051]1) Select the luteolin disulfonated derivative MXCS-diSO with a virtual screening normalized FitValue score of 0.3966 in Example 1 3 Na(DUT202001), MXCS-diSO of luteolin disulfonated ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of biology and medicine, and relates to a small molecule inhibitor for blocking the combination of COVID-19 spike protein and human angiotensin-converting enzyme 2 and use thereof. Through virtual screening, experiments of blocking the combination of COVID-19 spike-like protein and human angiotensin-converting enzyme 2, and anti-viral transcription experiments, the present invention found that within the range of 0.5-500 μM, the combination of COVID-19 spike-like protein and human angiotensin-converting enzyme 2 The binding of human angiotensin-converting enzyme 2 has an inhibitory effect, a small molecule inhibitor that blocks the transfer of COVID-19 into cells, and can be used to prepare a drug for preventing and treating novel coronavirus infection.

Description

technical field [0001] The invention belongs to the technical field of biology and medicine, and relates to a small molecule inhibitor for blocking the combination of COVID-19 spike protein and human angiotensin-converting enzyme 2 and uses thereof, in particular, relates to efficient and specific prevention and treatment of novel coronavirus infection compounds and their applications. Background technique [0002] Novel coronavirus pneumonia, referred to as "new coronary pneumonia", is an acute infectious disease caused by the 2019 novel coronavirus (COVID-19) infection. After a person is infected with the new coronavirus, the main symptoms include respiratory symptoms, fever, cough, shortness of breath, and difficulty breathing. In more severe cases, the infection can lead to pneumonia, severe acute respiratory syndrome, renal failure, and even death. At present, there is a lack of effective antiviral drugs against the pathogens for the diseases caused by the new coronavi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D311/30A61P31/14A61P11/00A61K31/7036A61K31/165A61K31/352A61K31/05A61K38/08
CPCC07D311/30A61P31/14A61P11/00A61K31/7036A61K31/165A61K31/352A61K31/05A61K38/08A61K2300/00
Inventor 李悦青苗露赵伟杰徐兆超潘霞周伟孙萌萌左雨薇
Owner DALIAN UNIV OF TECH